Literature DB >> 32372881

Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer.

Agata Jodda1, Tomasz Piotrowski1,2, Marta Kruszyna-Mochalska1,2, Julian Malicki1,2.   

Abstract

PURPOSE: To analyse the impact of different optimization strategies on the compatibility between planned and delivered doses during radiotherapy of cervical cancer. MATERIAL/
METHODS: Four treatment plans differing in optimisation strategies were prepared for ten cervical cancer cases. These were: volumetric modulated arc therapy with (_OPT) and without optimization of the doses in the bone marrow and for two sets of margins applied to the clinical target volume that arose from image guidance based on the bones (IG(B)) and soft tissues (IG(ST)). The plans were subjected to dosimetric verification by using the ArcCHECK system and 3DVH software. The planned dose distributions were compared with the corresponding measured dose distributions in the light of complexity of the plans and its deliverability.
RESULTS: The clinically significant impact of the plans complexity on their deliverability is visible only for the gamma passing rates analysis performed in a local mode and directly in the organs. While more general analyses show statistically significant differences, the clinical relevance of them has not been confirmed. The analysis showed that IG(ST)_OPT and IG(B)_OPT significantly differ from IG(ST) and IG(B). The clinical acceptance of IG(ST)_OPT obtained for hard combinations of gamma acceptance criteria (2%/2 mm) confirm its satisfactory deliverability. In turn, for IG(B)_OPT in the case of the rectum, the combination of 2%/2 mm did not meet the criteria of acceptance.
CONCLUSION: Despite the complexity of the IG(ST)_OPT, the results of analysis confirm the acceptance of its deliverability when 2%/2 mm gamma acceptance criteria are used during the analysis.
© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3DVH software.; Cervical cancer; Treatment plan complexity; VMAT; gamma analysis

Year:  2020        PMID: 32372881      PMCID: PMC7191125          DOI: 10.1016/j.rpor.2020.03.027

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  35 in total

1.  A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation.

Authors:  Tom Depuydt; Ann Van Esch; Dominique Pierre Huyskens
Journal:  Radiother Oncol       Date:  2002-03       Impact factor: 6.280

2.  Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.

Authors:  Kevin Albuquerque; David Giangreco; Courtney Morrison; Mohammed Siddiqui; Jim Sinacore; Ronald Potkul; John Roeske
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-12       Impact factor: 7.038

Review 3.  A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer.

Authors:  R Jadon; C A Pembroke; C L Hanna; N Palaniappan; M Evans; A E Cleves; J Staffurth
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-02-22       Impact factor: 4.126

4.  Multi-centre audit of VMAT planning and pre-treatment verification.

Authors:  Diego Jurado-Bruggeman; Victor Hernández; Jordi Sáez; David Navarro; Francisco Pino; Tatiana Martínez; Maria-Elena Alayrach; Norbert Ailleres; Alejandro Melero; Núria Jornet
Journal:  Radiother Oncol       Date:  2017-07-04       Impact factor: 6.280

5.  Statistical analysis of the gamma evaluation acceptance criteria: A simulation study of 2D dose distributions under error free conditions.

Authors:  Svjetlana Sunjic; Crister Ceberg; Tomislav Bokulic
Journal:  Phys Med       Date:  2018-06-21       Impact factor: 2.685

6.  Treatment plan complexity metrics for predicting IMRT pre-treatment quality assurance results.

Authors:  S B Crowe; T Kairn; J Kenny; R T Knight; B Hill; C M Langton; J V Trapp
Journal:  Australas Phys Eng Sci Med       Date:  2014-05-09       Impact factor: 1.430

7.  Comparison of two different EPID-based solutions performing pretreatment quality assurance: 2D portal dosimetry versus 3D forward projection method.

Authors:  Sara Bresciani; Matteo Poli; Anna Miranti; Angelo Maggio; Amalia Di Dia; Christian Bracco; Pietro Gabriele; Michele Stasi
Journal:  Phys Med       Date:  2018-06-26       Impact factor: 2.685

8.  Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.

Authors:  Ann H Klopp; Jennifer Moughan; Lorraine Portelance; Brigitte E Miller; Mohammad R Salehpour; Evangeline Hildebrandt; Jenny Nuanjing; David D'Souza; Luis Souhami; William Small; Rakesh Gaur; Anuja Jhingran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-01       Impact factor: 7.038

9.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

10.  Clinical and dosimetric factors associated with the development of hematologic toxicity in locally advanced cervical cancer treated with chemotherapy and 3D conformal radiotherapy.

Authors:  Miguel Ángel Souto-Del Bosque; Miguel Ángel Cervantes-Bonilla; Gerardo Del Carmen Palacios-Saucedo
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-13
View more
  5 in total

1.  Dosimetric impact of Acuros XB on cervix radiotherapy using RapidArc technique: a dosimetric study.

Authors:  Lalit Kumar; Vimal Kishore; Manindra Bhushan; Pawan Kumar; Rahul Lal Chaudhary
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

2.  Efficiency of a novel non-monotonic segmented leaf sequence delivery of Varian MLC for non-split IMRT fields.

Authors:  Rose Kamal; Gaganpreet Singh; Deepak Thaper; Arun S Oinam; Bhumika Handa; Vivek Kumar; Rakesh Kapoor
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-08

3.  Analysis of the planned, delivered dose distributions and quality assurance for helical tomotherapy and volumetric modulated arc therapy in locally advanced non-small cell lung cancer.

Authors:  Pitchayaponne Klunklin; Tamisa Manoharn; Somsak Wanwilairat; Wannapha Nobnop; Anirut Watcharawipha; Imjai Chitapanarux
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

4.  Radiation Exposure of Crystalline Bodies during Interventional Therapy and Related Research Status.

Authors:  Yahong Chen; Dong Zhao; Hongwei Zhong; Yiheng Zhang; Donghong An
Journal:  Contrast Media Mol Imaging       Date:  2022-07-31       Impact factor: 3.009

5.  Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer.

Authors:  Tomasz Piotrowski; Slav Yartsev; Jaroslaw Krawczyk; Marta Adamczyk; Agata Jodda; Julian Malicki; Piotr Milecki
Journal:  Life (Basel)       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.